Find information on Portal Hypertensive Gastropathy diagnosis, including clinical documentation, medical coding (ICD-10 K76.8, CPT), endoscopic findings, and treatment. Learn about gastric antral vascular ectasia (GAVE), symptoms, management, and the role of healthcare professionals in diagnosing and documenting this condition. Explore resources for accurate and efficient clinical documentation and coding related to Portal Hypertension and its associated gastropathy.
Also known as
Esophageal varices with bleeding
Bleeding from enlarged veins in the esophagus, often due to portal hypertension.
Esophageal varices without bleeding
Enlarged veins in the esophagus without bleeding, often due to portal hypertension.
Portal hypertension
Elevated blood pressure in the portal vein, often leading to gastropathy.
Acute gastric ulcer with bleeding
Although not specific to portal hypertension, bleeding ulcers can be a complication.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the gastropathy due to portal hypertension?
When to use each related code
| Description |
|---|
| Portal hypertension-related stomach changes |
| Gastric antral vascular ectasia (GAVE) |
| Gastric varices |
Coding portal hypertensive gastropathy without specifying the underlying cause (e.g., cirrhosis) can lead to rejected claims and inaccurate data.
Misdiagnosis of other gastrointestinal bleeding conditions as portal hypertensive gastropathy can result in incorrect coding and impact quality metrics.
Insufficient documentation linking portal hypertension to the gastropathy can cause coding denials and compliance issues during audits.
Patient presents with symptoms suggestive of portal hypertensive gastropathy (PHG). Key findings include [insert specific symptoms e.g., anorexia, nausea, early satiety, abdominal discomfort, melena, hematemesis, or iron deficiency anemia]. Physical examination revealed [document relevant findings e.g., splenomegaly, ascites, or other signs of portal hypertension]. Underlying liver disease, specifically [specify diagnosed liver disease e.g., cirrhosis, nonalcoholic steatohepatitis (NASH), or hepatitis C], has been previously established. Esophagogastroduodenoscopy (EGD) performed on [date] demonstrated characteristic endoscopic findings of PHG, including [describe findings e.g., mosaic-like appearance of the gastric mucosa, erythema, or cherry-red spots]. Histological examination of biopsies obtained during the EGD confirmed the diagnosis of PHG, revealing [describe histological findings e.g., dilated mucosal capillaries, and fibrin thrombi]. The patient's clinical presentation, endoscopic findings, and histological examination are consistent with the diagnostic criteria for portal hypertensive gastropathy. Assessment includes a Child-Pugh score of [insert score] and MELD score of [insert score], indicating [severity level e.g., mild, moderate, or severe] liver dysfunction. Differential diagnoses considered included gastric antral vascular ectasia (GAVE), peptic ulcer disease, and gastric malignancy, which were ruled out based on endoscopic and histological findings. Treatment plan includes [specify treatment plan e.g., non-selective beta-blocker therapy with propranolol or nadolol for portal hypertension management, endoscopic therapy for active bleeding if present, iron supplementation for anemia, and nutritional support]. Patient education provided regarding dietary modifications, medication adherence, and the importance of regular follow-up. Follow-up EGD scheduled in [duration] to assess response to therapy and monitor for disease progression. Coding considerations include ICD-10-CM code K76.6 for portal hypertensive gastropathy and appropriate CPT codes for the EGD and any endoscopic interventions performed.